...
首页> 外文期刊>Aesthetic plastic surgery >Effect of pregabalin and dexamethasone addition to multimodal analgesia on postoperative analgesia following rhinoplasty surgery
【24h】

Effect of pregabalin and dexamethasone addition to multimodal analgesia on postoperative analgesia following rhinoplasty surgery

机译:普瑞巴林和地塞米松联合多模态镇痛对鼻整形术后术后镇痛的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Background: We investigated the effect of a combination of pregabalin and dexamethasone, when used as part of a multimodal analgesic regimen, on pain control after rhinoplasty operations. Methods: Sixty patients were enrolled in this study. They were randomly assigned into three groups: Group C (placebo + placebo), Group P (pregabalin + placebo), and Group PD (pregabalin + dexamethasone). Patients received either pregabalin 300 mg orally 1 h before surgery, dexamethasone 8 mg intravenously during induction, or placebo according to their allocation. Postoperative pain was treated with intravenous patient-controlled analgesia (tramadol, 20-mg bolus dose, 45-min lockout time). The numeric rating scale (NRS), side effects, and consumption of tramadol, pethidine, and ondansetron were assessed. Results: The median NRS scores at 0, 1, and 6 h after surgery were significantly higher in Group C than in Group PD (p < 0.001 for all). The 24-h consumption of tramadol and pethidine was significantly reduced in Groups P and PD compared to Group C (p < 0.01 and p < 0.01). The total tramadol consumption was decreased by 54.5 % in Group P and 81.9 % in Group PD compared to Group C (p < 0.001 for both). The incidence of nausea was higher in Group C than in Groups P and PD between the postoperative 0-2 and 0-24-h periods (p < 0.05 for both). The frequency of blurred vision was significantly higher in Groups P and PD than in Group C within the 0-24-h period (p < 0.05 for both). Conclusion: We found that the addition of a single dose of pregabalin and dexamethasone to multimodal analgesia in rhinoplasty surgeries provided efficient analgesia and thus decreased opioid consumption.
机译:背景:我们研究了普瑞巴林和地塞米松联合使用作为多峰镇痛方案的一部分对隆鼻手术后疼痛控制的影响。方法:60例患者参加了这项研究。他们被随机分为三组:C组(安慰剂+安慰剂),P组(普瑞巴林+安慰剂)和PD组(普瑞巴林+地塞米松)。患者在手术前1小时口服普瑞巴林300 mg,诱导期间静脉内注射地塞米松8 mg,或根据分配情况使用安慰剂。术后疼痛采用静脉内自控镇痛(曲马多,20 mg推注剂量,45分钟锁定时间)治疗。评估了数字评分量表(NRS),副作用和曲马多,哌替啶和恩丹西酮的消耗量。结果:C组在手术后0、1和6 h的NRS得分中位数显着高于PD组(全部p <0.001)。与C组相比,P组和PD组的曲马多和哌替啶的24小时消耗量显着减少(p <0.01和p <0.01)。与C组相比,P组的曲马多总消费量减少了54.5%,PD组的总消费量减少了81.9%(两者均p <0.001)。在术后0-2和0-24-h期间,C组的恶心发生率高于P和PD组(两者均p <0.05)。在0-24小时内,P组和PD组的视物模糊频率显着高于C组(两者均p <0.05)。结论:我们发现在鼻整形手术中向多模式镇痛中添加单剂量的普瑞巴林和地塞米松可以提供有效的镇痛作用,从而减少阿片类药物的消耗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号